Supriya Lifescience has released its financial results for the quarter. The company recorded total revenue from operations of 145.07 Cr. Net profit after tax for the period stood at 34.79 Cr. These unaudited figures, crucial for assessing recent performance, were reviewed by the Audit Committee and approved by the Board of Directors, with a limited review conducted by statutory auditors.